Published in J Investig Med on April 01, 1996
Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res Ther (2008) 1.52
Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky. Arthritis Res Ther (2004) 1.07
Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. Arthritis Rheum (2008) 0.98
Angiogenesis in rheumatoid arthritis. Autoimmunity (2009) 0.95
Cell-cell interactions in synovitis. Endothelial cells and immune cell migration. Arthritis Res (2000) 0.93
Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation. Arthritis Res Ther (2014) 0.83
Tumor necrosis factor-alpha induces VCAM-1-mediated inflammation via c-Src-dependent transactivation of EGF receptors in human cardiac fibroblasts. J Biomed Sci (2015) 0.81
Accelerated development of arthritis in mice lacking endothelial selectins. Arthritis Res Ther (2005) 0.80
Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues. J Clin Pathol (1997) 0.80
Characterisation of fibroblast-like synoviocytes from a murine model of joint inflammation. Arthritis Res Ther (2013) 0.79
Suppressive effect of combination treatment of leflunomide and methotrexate on chemokine expression in patients with rheumatoid arthritis. Clin Exp Immunol (2003) 0.78
Parthenolide inhibits proliferation of fibroblast-like synoviocytes in vitro. Inflammation (2008) 0.77
NADPH Oxidase/ROS-Dependent VCAM-1 Induction on TNF-α-Challenged Human Cardiac Fibroblasts Enhances Monocyte Adhesion. Front Pharmacol (2016) 0.76
β1,4-galactosyltransferase-I in synovial tissue of collagen-induced rat model of rheumatoid arthritis. Clin Exp Med (2010) 0.75
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest (1998) 6.51
Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media. Appl Microbiol (1971) 3.38
Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol (1998) 3.05
Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol (1992) 2.08
Evidence of IL-18 as a novel angiogenic mediator. J Immunol (2001) 1.93
Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology (2000) 1.92
Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum (2001) 1.91
Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum (2001) 1.87
Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford) (2005) 1.81
Adhesion molecule expression in human synovial tissue. Arthritis Rheum (1993) 1.79
Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum (1986) 1.71
Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci U S A (1994) 1.65
Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum (1994) 1.64
Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum (1996) 1.60
Inhibition of angiogenesis by interleukin 4. J Exp Med (1998) 1.53
Thrombospondin 1 synthesis and function in wound repair. Am J Pathol (1996) 1.52
Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum (2001) 1.49
The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. J Lab Clin Med (1994) 1.44
[Favorable in vitro effect of pentoxifylline on damaged lymphocyte migration in arteriosclerosis obliterans and systemic lupus erythematosus]. Orv Hetil (1993) 1.39
[Angiotensin and its mediators. Their pathogenic and clinical significance in "angiogenic diseases"]. Orv Hetil (1998) 1.38
Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am J Pathol (2001) 1.36
Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum (2000) 1.31
IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol (2000) 1.31
Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol (2003) 1.27
Clinical findings in 61 patients with progressive systemic sclerosis. Acta Derm Venereol (1989) 1.25
The complex role of vitamin D in autoimmune diseases. Scand J Immunol (2008) 1.25
A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J Biol Chem (2001) 1.23
IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J Immunol (2001) 1.21
Chemokines and angiogenesis. Curr Opin Rheumatol (2001) 1.20
The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis. J Immunol (1999) 1.18
Cellular components and features of immune response in abdominal aortic aneurysms. Ann N Y Acad Sci (1996) 1.17
Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol (2000) 1.17
Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation. Agents Actions (1994) 1.15
RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin Immunol Immunopathol (1998) 1.13
Chemokines in rheumatoid arthritis. Springer Semin Immunopathol (1998) 1.12
Lymphocyte surface immunoglobulins in autoimmune diseases. Lancet (1973) 1.11
Interleukin-18 induces rheumatoid arthritis synovial fibroblast CXC chemokine production through NFkappaB activation. Lab Invest (2001) 1.11
Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum (2001) 1.11
Induction of neovascularization by activated human monocytes. J Leukoc Biol (1986) 1.09
Interleukin-1 beta and tumor necrosis factor-alpha release in normal and diseased human infrarenal aortas. J Vasc Surg (1992) 1.06
Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance. J Investig Med (1998) 1.06
Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. The possible role of these cytokines in human aortic aneurysmal blood vessel growth. Pathobiology (1994) 1.05
Update on synovitis. Curr Rheumatol Rep (2001) 1.05
Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. J Immunol (1994) 1.02
Comparative study on the interferon production by the leukocytes of healthy and leukaemic subjects. Acta Microbiol Acad Sci Hung (1967) 1.02
Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications. Rheumatology (Oxford) (2007) 1.02
Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol (2000) 1.01
Antiphospholipid antibodies in acute coronary syndrome. Lupus (2004) 1.00
Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype. Clin Exp Immunol (1999) 1.00
Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Lupus (2007) 0.99
Enzyme-linked immunosorbent assay for antibodies to native DNA in sera of patients with SLE. J Immunol Methods (1982) 0.99
Chronic lupus peritonitis with ascites: review of the literature with a case report. Semin Arthritis Rheum (1988) 0.98
Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis: possible interactions in the pathogenesis of the disease. Clin Immunol Immunopathol (1995) 0.98
Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases. Neth J Med (2011) 0.97
The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scand J Rheumatol (2010) 0.97
T and B lymphocytes in pregnancy. Klin Wochenschr (1974) 0.97
Unidirectional crosstalk between Bcl-xL and Bcl-2 enhances the angiogenic phenotype of endothelial cells. Cell Death Differ (2007) 0.97
Factor XIII of blood coagulation in human monocytes. Thromb Res (1985) 0.97
Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention. Drugs Aging (1998) 0.96
Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis. Arthritis Rheum (2000) 0.96
TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol (2006) 0.96
Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium. J Immunol (2000) 0.95
Endogenous lipoid pneumonia associated with undifferentiated connective tissue disease (UCTD). Med Sci Monit (2001) 0.95
Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Rheumatology (Oxford) (2008) 0.95
Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope. Clin Exp Rheumatol (2008) 0.95
Localized scleroderma after exposure to organic solvents. Dermatology (1994) 0.95
Soluble E-selectin induces monocyte chemotaxis through Src family tyrosine kinases. J Biol Chem (2001) 0.94
Diagnostic significance of HLA-DQ typing in patients with previous coeliac disease diagnosis based on histology alone. Aliment Pharmacol Ther (2006) 0.94
Cell-cell interactions in synovitis. Endothelial cells and immune cell migration. Arthritis Res (2000) 0.93
Survival analysis of 118 patients with systemic sclerosis. J Intern Med (1993) 0.93
Cellular adhesion molecules in rat adjuvant arthritis. Arthritis Rheum (1996) 0.93
Retrospective analysis of patients with lupus nephritis: data from a large clinical immunological center in Hungary. Scand J Immunol (2006) 0.92
Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria. Br J Dermatol (2006) 0.92
Evaluation of different methods for detecting circulating immune complexes. An inter-laboratory study. J Immunol Methods (1980) 0.92
Effect of soluble immune complexes of Fc and C3 receptor-dependent phagocytosis by human monocytes. Immunology (1981) 0.92
Correlations of monocyte phagocytic receptor expressions with serum immune complex level in systemic lupus erythematosus. Scand J Immunol (1994) 0.92
Circulating immune complexes and monocyte Fc function in autoimmune diseases. Ann Rheum Dis (1979) 0.91
Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis. Ann Rheum Dis (2005) 0.91
Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Lupus (2007) 0.90
Release of adenosine from human neutrophils stimulated by platelet activating factor, leukotriene B(4) and opsonized zymosan. Mediators Inflamm (1992) 0.90
Association of host antigens with a parainfluenza virus. Virology (1965) 0.90
Differential expression pattern of the antiapoptotic proteins, Bcl-2 and FLIP, in experimental arthritis. Arthritis Rheum (2001) 0.89
Myelofibrosis in systemic lupus erythematosus. Leuk Lymphoma (2000) 0.89
Letter: Immune complexes in Hodgkin's disease. Lancet (1976) 0.87
Intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells: a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms. Clin Exp Immunol (1994) 0.87
Gamma/delta T cell receptor positive T cells in the inflammatory joint: lack of association with response to soluble antigens. Cell Immunol (1991) 0.87
Radioassay of soluble immune complexes using their uptake by macrophage Fc receptors. Immunology (1977) 0.87
The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients. Autoimmunity (2007) 0.87
Systemic sclerosis and exposure to trichloroethylene. Dermatology (1993) 0.86
Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension. Scand J Immunol (2006) 0.86
Impaired regulatory T-cell homeostasis due to vitamin D deficiency in undifferentiated connective tissue disease. Scand J Rheumatol (2010) 0.86
Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications. Scand J Rheumatol (2010) 0.86
Binding and endocytosis of erythrocytes sensitized with rabbit IgG via Fc gamma receptors of human monocytes. Immunology (1991) 0.86
Plasma endothelin correlates with antiendothelial antibodies in patients with mixed connective tissue disease. Circulation (1995) 0.86
Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1995) 0.86
Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis. Arthritis Rheum (1999) 0.86
HL-A and systemic lupus erythematosus. Haematologia (Budap) (1973) 0.86
Soluble forms of P-selectin and intercellular adhesion molecule-3 in synovial fluids. Clin Immunol Immunopathol (1996) 0.85